Responsive image

Save this Event to your Calendar


The Scientific Program will be realized based on the Central European Time (CET) + 1 hr

Scientific Program

Monday 08-11-2021

       

16.25-16.30 Welcome and introductions G. Dimopoulos

16.30-17.00

Satellite Lecture Biosurg
Chair: Koutsoukou A

Speaker
16.30-16.50 Clinical application of airway clearance in patients with COVID-19 and ICU Xiaohe Li
16.50-17.00 Q & A / Discussion  

       

17.00-17.45

Management of the critically ill patients in the Emergency Department (ED) and ICU: different pieces of the same puzzle
Chair: G. Filippatos


Speaker
17.00-17.15 ...ICU point of view P. Myrianthefs
17.15-17.30 ...ED point of view E. Polyzogopoulou
17.30-17.45 Q & A / Discussion  

       

17.45-18.15

Satellite Lecture Roche
Chair: I. Ikonomidis

Speaker
17.45-18.05 Implementation of high sensitivity cardiac troponin T measurement in the emergency department J. Parissis
18.05-18.15 Q & A / Discussion  

         

18.15-19.45

New concepts in the management of the critically ill patient in the ED
Chair: J. Parissis

Speaker
18.15-18.30 Point of care ultrasound in undifferentiated shock E. Polyzogopoulou
18.30-18.45 Role of biomarkers K. Ntai
18.45-19.00 Advances in the airway management A. Boultadakis
19.00-19.15 ECMO in the ED S. Dimopoulos
19.15-19.30 Advances in management of cardiogenic shock J. Parissis
19.30-19.45 Q & A / Discussion

Tuesday 09-11-2021

       

08.55-09.00 Official commencement of the Scientific Program of the Conference,
by the President of the National Public Health Organization (NPHO)
T. Zaoutis

09.00-11.00

Fungal Infections
Chairs: T. Zaoutis - H. Magira

Speaker
09.00-09.15 IFIs : The epideliology is changing T. Zaoutis
09.15-09.30 Antifungal stewardship J.A. Paiva
09.30-09.45 A breakthrough IFI: how to treat it ? M. Ghannoum
09.45-10.00 The optimal antifungal dose? P. Montravers
10.00-10.15 Rare mould infections: The new guidelines O. Cornely
10.15-10.30 Pathogenesis of fungal-bacterial mixed biofilms M. Richardson
10.30-11.00 Q & A / Discussion  

       

11.00-12.00

Satellite Symposium Biomerieux
Chair: C. Gogos - A. Koutsoukou

Speaker
11.00-11.20 The Value of Syndromic Diagnostic Panels for Infectious Diseases in AMS Programs D. Kofteridis
11.20-11.40 Real Life Experience of BioFire Pneumonia Panel and it’s Clinical Value K. Pontikis
11.40-12.00 Q & A / Discussion  

     

12.00-13.00 Break

     

13.00-14.45

How to treat...
Chairs: Z.D. Pana - E. Mouloudi

Speaker
13.00-13.15 …XDR/PDR infections M. Akova
13.15-13.30 …MDR endocarditis E. Giannitsioti
13.30-13.45 …CAP patients P. Bakakos
13.45-14.00 …and for how long Legionella spp pneumonia J.A. Paiva
14.00-14.15 …cSSTIs C. Eckmann
14.15-14.45 Q & A / Discussion  

     

14.45-15.00 Break

         

15.00-16.45

Sepsis and other
Chairs: A. Kotanidou - N. Rovina

Speaker
15.00-15.15 Genetic predisposition against fungi? M. Richardson
15.15-15.30 Artificial Intelligence and infections I. Mporas
15.30-15.45 Biomarkers in sepsis: any specific for different patient groups? E. Eckmann
15.45-16.00 PCT guided antimicrobials M. Akova
16.00-16.15 Mycobiome in health and disease M. Ghannoum
16.15-16.45 Q & A / Discussion

     

16.45-17.00 Break

         

17.00-18.00

Satellite Symposium Pfizer
The clinical burden of pneumococcus in the midst of SARS-COV-2 pandemic
Chair: A. Pefanis


Speaker
17.00-17.40 The contribution of the 13-valent conjugated pneumococcal vaccine to the prevention of pneumococcal infections D. Kofteridis
17.40-18.00 Q & A / Discussion  

         

18.00-19.00

T2MR
Chairs: G. Vlachogianni - E. Antoniadou

Speaker
18.00-18.20 T2Biosystems: Enabling Changes in Clinical Decisions and Outcomes M. Broek-Kuehbauch
18.20-18.40 Evaluation of T2MR in a Greek university intensive care unit C. Vrettou
18.40-19.00 Q & A / Discussion  

         

19.00-20.00

Satellite Symposium Amomed
Decatecholaminization in the ICU
Chair: D. Georgopoulos


Speaker
19.00-19.20 Vasopressin. Do we really need another vasopressor? V. Papaioannou
19.20-19.40 Landiolol. Arrhythmias management and beyond D. Makris
19.40-20.00 Q & A / Discussion  

Wednesday 10-11-2021

       

09.00-11.00

COVID-19 Pandemic I
Chairs: N. Koulouris - A. Komnos

Speaker
09.00-09.15 The 5 phenotypes of COVID-19 J. Rello
09.15-09.30 Pathophysiology of COVID-19 J.F. Timsit
09.30-09.45 Hypercoagulable phase of COVID-19 S. Konstandinides
09.45-10.00 COVID-19 and PRES syndrome S. Mentzelopoulos
10.00-10.15 The mechanism of immune response to COVID-19 E. Giamarellos
10.15-10.30 How to ventilate COVID-19 patients D. Georgopoulos
10.30-11.00 Q & A / Discussion  

       

11.00-12.00

Satellite Symposium Gilead
COVID-19: Antiviral treatment and management of COVID-19 associated fungal complications
Chair: G. Dimopoulos



Speaker
11.00-11.25 The antiviral management of hospitalized patients with COVID-19 K. Pontikis
11.25-11.50 COVID-19 Associated Invasive Fungal Infections N. Sipsas
11.50-12.00 Q & A / Discussion  

     

12.00-13.00 Break

     

13.00-14.45

COVID-19 Pandemic II
Chairs: H. Sambatakou - G. Stratakos

Speaker
13.00-13.15 COVID Associated Aspergillosis O. Cornely
13.15-13.30 Other IFIs associated with COVID-19 P. Montravers
13.30-13.45 Secondary Bacterial Infections in COVID patients M. Kollef
13.45-14.00 Pulmonary complications of COVID-19 J.F Timsit
14.00-14.15 Cardiac complications of COVID-19 I. Ikonomidis
14.15-14.45 Q & A / Discussion  

     

14.45-15.00 Break

         

15.00-16.45

COVID-19 Pandemic III
Chairs: Z.D. Pana - P. Bakakos

Speaker
15.00-15.15 Anticoagulant therapy in COVID-19 patients S. Konstandinides
15.15-15.30 COVID in immunocompromised patients E. Azoulay
15.30-15.45 Antiviral treatment M. Bassetti
15.45-16.00 Antiiflammatory treatment E. Giamarellos
16.00-16.15 Plasma treatment M.A. Dimopoulos
16.15-16.45 Q & A / Discussion

     

16.45-17.00 Break

         

17.00-18.00

Satellite Symposium Pfizer
Discussing on hot topics in infectious diseases
Chairs: D. Georgopoulos - A. Koutsoukou


Speaker
17.00-17.30 MDR Gram-negative infections G. Daikos
17.30-18.00 Invasive mould infections in ICU G. Dimopoulos

         

18.00-19.00

"Old" and New Antibiotics
Chairs: I. Pnevmatikos - E. Zakynthinos

Speaker
18.00-18.25 Satellite lecture Menarini: Meropenem- Vaborbactam: a new weapon in the ICU E. Giamarellos
18.25-18.30 Q & A / Discussion  
18.30-18.55 Fosfomycin IV in difficult to treat Gram (-) infections S. Assimakopoulos
18.55-19.00 Q & A / Discussion  

         

19.00-19.30

Satellite lecture Norma Hellas
Chair: A. Koutsoukou

Speaker
19.00-19.20 Nebulized antibiotics- an update J. Rello
19.20-19.30 Q & A / Discussion  

Thursday 11-11-2021

       

09.00-11.00

Infections in transplant patients
Chairs: A. Koutsoukou - N. Arkadopoulos

Speaker
09.00-09.15 Fungal infections in transplant patients J. Meletiadis
09.15-09.30 Bacterial infections in transplant patients J. Rello
09.30-09.45 Viral infections in transplant patients J. Chastre
09.45-10.00 Infections in haematopoetic stem cell transplantation E. Terpos
10.00-10.15 Antifungal prophylaxis in lung transplant patients A. Vena
10.15-10.30 Sepsis in solid organ transplant: a different outcome? E. Azoulay
10.30-11.00 Q & A / Discussion  

       

11.00-12.00

Satellite Symposium 3M
Chair: C. Gogos

Speaker
11.00-11.20 Protecting your patients from CRBSIs in the Covid 19 Era G. Theodorakopoulos
11.20-11.50 Workshop - Protect all vascular access points with innovative technologies G. Theodorakopoulos
11.50-12.00 Q & A / Discussion  

     

12.00-13.00 Break

     

13.00-14.45

PK/PDs in the critically ill patient
Chairs: E. Zakynthinos - A. Dokoumetzidis

Speaker
13.00-13.15 TDM: antibiotic, patient, infection. When and how? R. Lewis
13.15-13.30 PK/PDs from the part of the pharmacist C. Petrou
13.30-13.45 PK/PDs of antibiotics in pregnancy D. Nicolau
13.45-14.00 An ICU patient on CRRT or ECMO: which is the right dose? R. Lewis
14.00-14.15 %TMIC is enough for the confirmation of the adequate dose? D. Nicolau
14.15-14.45 Q & A / Discussion  

     

14.45-15.00 Break

         

15.00-16.45

The future
Chairs: S. Orfanos - P. Myrianthefs

Speaker
15.00-15.15 Molecular imaging of pathogens S. Pournaras
15.15-15.30 Bacteriophages; the futured treatemnt of infections? M. Kollef
15.30-15.45 Metabolomics in sepsis M. Netea
15.45-16.00 Sepsis endotypes M. Netea
16.00-16.15 Monoclonal antibodies for preemptive treatment of bacterial infections in the ICU J. Chastre
16.15-16.45 Q & A / Discussion

     

16.45            End of Meeting